Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
IL15
Name:
interleukin 15
Location:
04q31.21
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT03056339 | Umbilical Cord Blood CB Derived CAR-Engineered NK Cells for B Lymphoid Malignancies | View | |
| NCT04324996 | A Phase III Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | View | |
| NCT04715191 | Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors | View | |
| NCT04377932 | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors | View | |
| NCT05103631 | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors | View | |
| NCT06251544 | TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor CAR T Cells for the Treatment of Metastatic Breast Cancer | View | |
| NCT05922930 | Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer Mesonephric-like Adenocarcinoma and Pancreatic Cancer | View | |
| NCT03579927 | CARCD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells High-Dose Chemotherapy and Stem Cell Transplant in Treating Participants With B-cell Lymphoma | View | |
| NCT06198296 | Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells | View | |
| NCT01994824 | Preemptive Therapy of GVHD | View | |
| NCT01189383 | IL15 Dendritic Cell Vaccine for Patients With Resected Stage III A B or C or Stage IV Melanoma | View | |
| NCT01727076 | Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma Kidney Cancer Non-small Cell Lung Cancer or Squamous Cell Head and Neck Cancer | View | |
| NCT05703854 | Study of CAR70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma Mesothelioma and Osteosarcoma | View | |
| NCT05470283 | Phase I Open-Label Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma | View | |
| NCT06325748 | SENTI-202 Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 andor FLT3 Blood Cancers Including AMLMDS | View | |
| NCT05110742 | Phase III Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of RelapsedRefractory Hematological Malignances | View | |
| NCT05020678 | NKX019 Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells CAR NK in Adults With B-cell Cancers | View | |
| NCT04623944 | NKX101 Intravenous Allogeneic CAR NK Cells in Adults With AML or MDS | View | |
| NCT06060613 | Safety and Efficacy of OBX-115 in Advanced Solid Tumors | View | |
| NCT05092451 | Phase III Study of CAR70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of RelapseRefractory Hematological Malignances | View | |
| NCT05396391 | A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors | View | |
| NCT05964361 | First-in-human Interleukin-15-transpresenting Wilms Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients | View | |
| NCT06066424 | Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors TROPIKANA | View |